Novel Variants in KMT2C Further Support a Neurodevelopmental Disorder Distinct From Kleefstra and Kabuki Syndromes
Molecular Genetics & Genomic Medicine · 2026-04 · 14 (4)
DOI: 10.1002/mgg3.70209 ↗Kurz gefasst
Fallbericht in der Zeitschrift Molecular Genetics & Genomic Medicine, online erschienen am 31.03.2026. Verfasst von Lucie Sedláčková und 3 weiteren Autor:innen. Beteiligte Einrichtung: Neurogenetic Laboratory, Department of Pediatric Neurology, Second Faculty of Medicine, Charles University in Prague and Motol and Homolka University…. Hauptthemen laut MEDLINE: Abnormalities, Multiple, Vestibular Diseases, Hematologic Diseases, Craniofacial Abnormalities. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministerstvo Zdravotnictví Ceské Republiky.
Abstract (Originalsprache)
Background
Heterozygous loss‐of‐function variants in the KMT2C gene were only recently recognized as a cause of neurodevelopmental disorder distinct from Kleefstra and Kabuki 1 syndromes. KMT2C ‐related neurodevelopmental disorder is characterized by developmental delay, intellectual disability, behavioral and psychiatric problems, seizures, craniofacial dysmorphism, and other comorbidities. Here we describe detailed phenotypes of three additional patients with novel variants in the KMT2C gene. Methods and Results Using exome sequencing, we found two heterozygous variants c.3212G>A, p.(Trp1071*) and c.13204_13205delinsA, p.(Cys4402Ilefs*11) leading to premature stop codon and one heterozygous missense variant c.6517C>T, p.(Pro2173Ser) in the KMT2C gene (NM_170606.3) in patients with unrecognized neurodevelopmental disorder. Our patients suffer from developmental delay, speech delay, autism spectrum disorder, cognitive impairment, seizures, and/or craniofacial dysmorphism.
Conclusion
After detailed phenotype analysis and by comparison with previous reports, we found that our patients have very similar phenotypes as described before and thus further extend the list of KMT2C causal variants. Therefore, we believe that they fit into these previously described phenotypes of KMT2C ‐related Kleefstra syndrome 2 as well.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neurogenetic Laboratory, Department of Pediatric Neurology, Second Faculty of Medicine, Charles University in Prague and Motol and Homolka University Hospital, Prague, Czech Republic.
- Biology and Medical Genetics, Second Faculty of Medicine, Charles University in Prague and Motol and Homolka University Hospital, Prague, Czech Republic.
ORCID-Profile: Lucie Sedláčková
Förderung
- Ministerstvo Zdravotnictví Ceské Republiky
Zitieren
APA
Sedláčková, L., Brožková, D. Š., Havlovicová, M., & Laššuthová, P. (2026). Novel Variants in KMT2C Further Support a Neurodevelopmental Disorder Distinct From Kleefstra and Kabuki Syndromes. Molecular Genetics & Genomic Medicine, 14(4). https://doi.org/10.1002/mgg3.70209
Vancouver
Sedláčková L, Brožková DŠ, Havlovicová M, Laššuthová P. Novel Variants in KMT2C Further Support a Neurodevelopmental Disorder Distinct From Kleefstra and Kabuki Syndromes. Molecular Genetics & Genomic Medicine. 2026;14(4). doi:10.1002/mgg3.70209
BibTeX
@article{Sedlkov2026,
author = {Sedláčková, Lucie and Brožková, Dana Šafka and Havlovicová, Markéta and Laššuthová, Petra},
title = {Novel Variants in KMT2C Further Support a Neurodevelopmental Disorder Distinct From Kleefstra and Kabuki Syndromes},
journal = {Molecular Genetics & Genomic Medicine},
year = {2026},
volume = {14},
number = {4},
doi = {10.1002/mgg3.70209}
}
EUVIMED